VKTX
4:05 PM
Viking Therapeutics to Participate at Upcoming Investor Conferences
vikingtherapeutics.com
Catalyst Calendar
Wed, Sep 2, 2026
1 updatesWed, Jul 29, 2026
1 updatesVKTX
4:05 PM
Viking Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update
Enrollment • Phase 3Enrollment milestone Tue, Jun 30, 2026vikingtherapeutics.com
Thu, Jul 23, 2026
1 updatesVKTX
7:05 AM
Viking Therapeutics Appoints Dorothy Gemmell to Board of Directors
vikingtherapeutics.com
Wed, Jul 22, 2026
1 updatesVKTX
4:05 PM
Viking Therapeutics to Report Financial Results for Second Quarter 2026 on July 29, 2026
vikingtherapeutics.com
Wed, Jun 24, 2026
1 updatesVKTX
7:05 AM
Viking Therapeutics Announces Initiation of Phase 1 Study to Evaluate Novel Amylin Receptor Agonist VK3019 in Healthy Adults
Trial Start • Phase 1Trial initiation Wed, Jun 24, 2026vikingtherapeutics.com